RDW Redwire Corporation

¹ Excludes 1,177,916 shares of Common Stock issuable on exercise of redeemable warrants beneficially owned by the Reporting Persons that may not be exercised within the next 60 days.

¹ Excludes 1,177,916 shares of Common Stock issuable on exercise of redeemable warrants beneficially owned by the Reporting Persons that may not be exercised within the next 60 days.

¹ Excludes 1,177,916 shares of Common Stock issuable on exercise of redeemable warrants beneficially owned by the Reporting Persons that may not be exercised within the next 60 days.

¹ Excludes 1,177,916 shares of Common Stock issuable on exercise of redeemable warrants beneficially owned by the Reporting Persons that may not be exercised within the next 60 days.

² Excludes 733,283 shares of Common Stock issuable on exercise of redeemable warrants beneficially owned by the Reporting Persons that may not be exercised within the next 60 days.

This statement relates to shares of Common Stock, par value $0.0001 (the “Stock”) of Redwire Corporation (formerly known as Genesis Park Acquisition Corp.) (the “Issuer”). The principal executive office of the Issuer is located at 2000 Edwards Street, Suite B, Houston, Texas 77007. In connection with the Transactions described in Item 6 below, effective as of September 2, 2021, (1) all of the Issuer’s outstanding Class A Ordinary Shares, including the Class A Ordinary Shares owned by the Filers, were converted by operation of law into shares of Common Stock of the Issuer, and (2) all warrants to acquire Class A Ordinary Shares of the Issuer, including the warrants owned by the Filers, were converted by operation of law into warrants to acquire shares of Common Stock of the Issuer.

Item 2. Identity and Background

The persons filing this statement and the persons enumerated in Instruction C of Schedule 13D and, where applicable, their respective places of organization, general partners, directors, executive officers and controlling persons, and the information regarding them, are as follows:

Master Fund and Crescent Park GP are filing this statement jointly with the other Filers, but not as a member of a group and they expressly disclaim membership in a group. In addition, filing this Schedule 13D on behalf of Master Fund should not be construed as an admission that it is, and it disclaims that it is, a beneficial owner, as defined in Rule 13d-3 under the Act, of any of the Stock covered by this Schedule 13D.

Each Filer disclaims beneficial ownership of the Stock except to the extent of that person’s pecuniary interest therein.

Crescent Park is an investment adviser to several private investment funds, including Master Fund (collectively, the “Funds”). CPM GP is the general partner of Crescent Park. Crescent Park GP is the general partner of the Funds. Mr. Cohen is the controlling person of Crescent Park and Crescent Park GP.

The source and amount of funds used in purchasing the Stock and warrants to purchase the Stock were as follows:

This amount includes $5,000,000 paid by the Funds for 500,000 shares of the Issuer’s Common Stock in a PIPE Transaction (as defined in Item 6 below) on September 2, 2021, and $24,000,000 paid by the Funds for 2,400,000 of the Issuer’s Units (“Units”) on November 24, 2020, in connection with the Issuer’s initial public offering. Each Unit consisted of one Class A ordinary share of the Issuer and one-half of one redeemable warrant entitling the holder to purchase one Class A ordinary share of the Issuer at a price of $11.50 per share.

³ Includes $19,300,180.00 paid by the Master Fund from its working capital.

The Filers acquired the Stock for investment purposes. Crescent Park assisted management of the Issuer in analyzing and conducting due diligence on potential acquisition targets identified by the Issuer. The Issuer completed its initial business combination on September 2, 2021. Accordingly, Crescent Park does not intend to make any recommendations to Issuer’s directors and officers regarding any other potential acquisitions, mergers, reorganizations and liquidations of the Issuer and its subsidiaries.

The Filers will routinely monitor the Issuer regarding a wide variety of factors that affect their investment considerations, including, current and anticipated future trading prices of the Stock and other securities, the Issuer’s operations, assets, prospects, financial position, and business development, Issuer’s management, Issuer-related competitive and strategic matters, general economic, financial market and industry conditions, and other investment considerations. Depending on their evaluation of various factors, the Filers may take such actions regarding their holdings of the Issuer’s securities as they deem appropriate in light of circumstances existing from time to time. Such actions may include purchasing additional Stock in the open market, through privately negotiated transactions with third parties or otherwise, and selling at any time, in the open market, through privately negotiated transactions with third parties or otherwise, all or part of the Stock now owned or hereafter acquired by any of them. The Filers also may from time to time enter into or unwind hedging or other derivative transactions with respect to the Stock or pledge their interests in the Stock to obtain liquidity. In addition, from time to time the Filers and their representatives and advisers may communicate with other stockholders, industry participants and other interested parties about the Issuer.

The Filers have no present plan or proposal that relates to or would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D of the Act. However, the Filers may recommend action to the Issuer’s management, board of directors and stockholders. Any such actions could involve one or more of the events referred to in clauses (a) through (j) of Item 4 of Schedule 13D, including, potentially, one or more mergers, consolidations, sales or acquisitions of assets, change in control, issuances, purchases, dispositions or pledges of securities or other changes in capitalization.

The beneficial ownership of the Stock by each Filer on the date hereof is reflected on that Filer’s cover page. The percentage ownership of the Filers is based on 67,672,028 shares of Common Stock outstanding after the completion of the Transactions and the PIPE Transaction (as defined in Item 6 below), consisting of (1) 16,377,622 shares of Common Stock into which the Issuer’s outstanding Class A Ordinary Shares were converted by operation of law in connection with the Transactions, (2) 4,094,406 shares of Common Stock into which the Issuer’s Class B Ordinary Shares were converted by operation of law in connection with the Transactions, (3) 10,000,000 shares of Common Stock issued in the PIPE Transaction, and (4) 37,200,000 shares of Common Stock issued as part of the Transactions, all as reported in Amendment No. 1 to the Issuer’s Form S-4, filed on August 5, 2021.

The Filers engaged in the following transactions in the Stock in the 60 days preceding the date of this Schedule 13D. Purchases and sales made after September 2, 2021, were intended to rebalance the portfolios of the Funds.

⁴ The Master Fund purchased 372,638 of these shares for a price of $10 per share.
⁵ The Master Fund sold 44,266 of these shares for a price of $11.7892 per share.
⁶ The Master Fund sold 29,797 of these shares for a price of $11.8734 per share.
⁷ The Master Fund sold 14,219 of these shares for a price of $11.8090 per share.

The Filers engaged in the following transactions in warrants to purchase the Stock in the 60 days preceding the date of this Schedule 13D. Purchases and sales made after September 2, 2021, were intended to rebalance the portfolios of the Funds.

⁸ The Master Fund sold 29,189 of these warrants for a price of $2.6739 per share.
⁹ The Master Fund sold 41,458 of these warrants for a price of $2.5933 per share.
¹⁰ The Master Fund sold 14,497 of these warrants for a price of $2.4714 per share.

As of September 2, 2021, the Filers ceased to be the beneficial owner of more than five percent of the class of securities.

On March 25, 2021, the Issuer entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Shepard Merger Sub Corporation, a Delaware corporation and direct, wholly owned subsidiary of the Issuer, Redwire, LLC, a Delaware limited liability company (“Holdings”) and Cosmos Intermediate, LLC, a Delaware limited liability company and direct, wholly owned subsidiary of Holdings (the “Company”). In connection with the Merger Agreement, the Company and Holdings entered into a voting and support agreement (the “Voting Agreement”) with the Funds, pursuant to which the Funds have agreed (i) to vote in favor of adopting the Merger Agreement and the transactions contemplated thereby (the “Transactions”), amending and restating the Issuer’s amended and restated memorandum and articles of association and certain other matters at a special stockholders meeting and (ii) not elect to redeem the Stock or tender or submit it for redemption. Also in connection with the execution of the Merger Agreement, the Issuer entered into a subscription agreement (the “2021 Subscription Agreement”) with the Funds, pursuant to which the Funds agreed to purchase shares of the Stock at a purchase price of $10.00 per share (the “PIPE Financing”). The PIPE Financing and the Transactions were consummated on September 2, 2021. The 2021 Subscription Agreement provides for certain registration rights with respect to the Stock issued in the PIPE Financing and will terminate on the earlier to occur of the termination of the Merger Agreement and the mutual written agreement of the parties thereto.

In addition to the Voting Agreement and the 2021 Subscription Agreement, the Funds are parties to a Subscription Agreement dated November 18, 2020 (the “2020 Subscription Agreement”), with Genesis Park Holdings, the sponsor of the Issuer (the “Sponsor”), pursuant to which the Funds acquired a membership interest in the Sponsor for nominal consideration in connection with the purchase of the Units. The 2020 Subscription Agreement entitles the Funds to an aggregate interest in up to 11% of the founder shares of the Issuer held by the Sponsor, assuming an offering of $150,000,000 of Units, and subject to adjustment if the size of the Issuer’s initial public offering changes, if the underwriters exercise their overallotment option, if the Funds purchase fewer than 3,000,000 Units in the initial public offering or if the Funds do not hold a minimum number of ordinary shares at the time of the Issuer’s initial business combination.

The Funds’ interest in such founder shares will be treated the same in all material respects as the founder shares held by the Sponsor, except the Funds will forfeit their interest in the founder shares if they do not purchase a minimum number of Units sold in the Issuer’s initial public offering (subject to adjustment based on the size of the offering).

Pursuant to the 2020 Subscription Agreement, the Funds were not granted any material additional shareholder or other rights and were only issued a membership interest in the Sponsor with no right to control the Sponsor or vote or dispose of the founder shares (which will continue to be held by the Sponsor until following the Issuer’s initial business combination).

The foregoing description of the Voting Agreement, the 2021 Subscription Agreement and the 2020 Subscription Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of such agreement, which is incorporated herein by reference.

Exhibit A Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G.

Exhibit B Subscription Agreement among the Funds and the Sponsor, in the form attached as Exhibit 10.18 to the Issuer’s Form 8-K (No. 001-39733), filed on November 27, 2020, and incorporated herein by reference.

Exhibit C Voting and Support Agreement among the Funds, the Company and Holdings, in the form attached as Exhibit C to Amendment No. 1 to the Filers’ Schedule 13D, filed on March 30, 2021.

Exhibit D Subscription Agreement among the Funds and the Issuer, in the form attached as Exhibit 10.2 to the Issuer’s Form 8-K (No. 001-39733), filed on March 25, 2021, and incorporated herein by reference.

SIGNATURES

After reasonable inquiry and to the best of my knowledge, I certify that the information set forth in this statement is true, complete and correct.

Dated: September 8, 2021

EXHIBIT A

AGREEMENT REGARDING JOINT FILING

OF STATEMENT ON SCHEDULE 13D OR 13G

The undersigned agree to file jointly with the Securities and Exchange Commission (the “SEC”) any and all statements on Schedule 13D, Schedule 13G or forms 3, 4 or 5 (and any amendments or supplements thereto) required under section 13(d) or 16(a) of the Securities Exchange Act of 1934, as amended, in connection with purchases by the undersigned of the securities of any issuer. For that purpose, the undersigned hereby constitute and appoint Crescent Park Management LP, a Delaware limited partnership, as their true and lawful agent and attorney-in-fact, with full power and authority for and on behalf of the undersigned to prepare or cause to be prepared, sign, file with the SEC and furnish to any other person all certificates, instruments, agreements and documents necessary to comply with section 13(d) and section 16(a) of the Act, in connection with said purchases, and to do and perform every act necessary and proper to be done incident to the exercise of the foregoing power, as fully as the undersigned might or could do if personally present.

Dated: September 8, 2021